Aesculus indica Hook.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Sapindaceae; Hippocastanaceae. |
| Habitat | The Himalayas from Kashmir to western Nepal, Kulu and Chamba in Himachal Pradesh, Tehri-Garhwal and Kumaon in Uttar Pradesh at 900–3,600 m. |
| English | Indian Horse Chestnut, Himalayan Chestnut. |
| Folk | Bankhor. |
| Action | Antirheumatic, galactogenic, antileucorrhocic. |
| Taxonomic Cohort | Genus Aesculus (2 documented species); Family Sapindaceae (8 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Aesculus indica (taxonomically cited with authority Hook.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Sapindaceae; Hippocastanaceae (primary family classification: Sapindaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: The Himalayas from Kashmir to western Nepal, Kulu and Chamba in Himachal Pradesh, Tehri-Garhwal and Kumaon in Uttar Pradesh at 900–3,600 m.
Across classical and vernacular Indian systems of medicine, Aesculus indica is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Indian Horse Chestnut, Himalayan Chestnut; in regional Indian folk and vernacular ethnobotany as Bankhor. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Aesculus indica are: Antirheumatic, galactogenic, antileucorrhocic. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Aesculus indica establish the following evidence base: The leaves contain aescin, quercetin and beta-sitosterol. Stems also contain rutin, astragalin, aesculin. Seeds contain aescin, aesculuside A and B, also aliphatic esters. Seeds possess antiinflammatory activity. The extract of seeds is considered to be active against P-388 lymphocytic leukaemia and human epidermoid carcinoma of nasopharynx.

Botanical Reference 1: Aesculus indica — Botanical specimen

Botanical Reference 2: Aesculus indica — Botanical specimen

Botanical Reference 3: Aesculus indica — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Aesculus comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Aesculus hippocastanum (Action: Anti-inflammatory, vasodilator, astringent (used for rheumatism, venous…). Comparing Aesculus indica alongside its congeners in genus Aesculus highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Sapindaceae encompasses 8 documented medicinal species (0.44% of the 1,814-species flora). Other representative medicinal members of Sapindaceae include: Cardiospermum halicacabum (Kaakatiktaa), Dodonaea viscosa (Raasnaa), Euphoria longan (Aakshiki), Litchi chinensis (Litchi), Sapindus laurifolius (Arishtaka). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 8 medicinal species of family Sapindaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Aesculus indica follow the plant-part modalities specified under its therapeutic action (Antirheumatic, galactogenic, antileucorrhocic), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Aesculus indica integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.